Electrophysiological Characterization of Cardiomyocytes Derived From Human Induced Pluripotent Stem Cells
Authors:
Open Access
- 1 January 2011
- journal article
- Published by Japanese Pharmacological Society in Journal of Pharmacological Sciences
- Vol. 117 (3) , 149-159
Abstract
Cardiomyocytes derived from human induced pluripotent stem cells (hiPS-CMs) hold great promise for development of in vitro research tools to assess cardiotoxicity, including QT prolongation. In the present study, we aimed to clarify the electrophysiological/pharmacological characteristics of hiPS-CMs using the patch-clamp technique. The hiPS cells were differentiated into beating cardiomyocytes by the embryoid body method. The expression of genes related to cardiac ion channels and differentiation markers in cardiomyocytes were detected by RT-PCR. Whole-cell patch-clamp recordings were performed using single hiPS-CMs dispersed from beating colonies. We confirmed voltage-dependence of major cardiac ion currents (INa, ICa, IKr, and IKs) and pharmacological responses to ion-channel blockers. Action potential duration (APD) was prolonged by both IKr/hERG and IKs blockers, whereas it was shortened by an ICa blocker, indicating that these ion current components contribute to action potential generation in hiPS-CMs. As for multiple ion channel blockers, terfenadine prolonged APD, but verapamil did not, results which were identical to clinically relevant pharmacological responses. These data suggest that patch-clamp assay using hiPS-CMs could be an accurate method of predicting the human cardiac responses to drug candidates. This study would be helpful in establishing an electrophysiological assay to assess the risk of drug-induced arrhythmia using hiPS-CMs.Keywords
This publication has 38 references indexed in Scilit:
- Evaluating the utility of cardiomyocytes from human pluripotent stem cells for drug screeningBiochemical Society Transactions, 2010
- Induced Pluripotent Stem Cells: A New Approach for Physiological ResearchCellular Physiology and Biochemistry, 2010
- Cardiomyocyte Differentiation of Human Induced Pluripotent Stem CellsCirculation, 2009
- In vitro pharmacologic testing using human induced pluripotent stem cell-derived cardiomyocytesBiochemical and Biophysical Research Communications, 2009
- Functional Cardiomyocytes Derived From Human Induced Pluripotent Stem CellsCirculation Research, 2009
- Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined FactorsCell, 2007
- Comparison of guinea-pig ventricular myocytes and dog Purkinje fibres for in vitro assessment of drug-induced delayed repolarizationJournal of Pharmacological and Toxicological Methods, 2007
- QT PRODACT: Comparison of Non-clinical Studies for Drug-Induced Delay in Ventricular Repolarization and Their Role in Safety Evaluation in HumansJournal of Pharmacological Sciences, 2005
- The impact of drug-induced QT interval prolongation on drug discovery and developmentNature Reviews Drug Discovery, 2003
- Voltage-dependent calcium channels: From structure to function1999